Page last updated: 2024-11-13

mahanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

mahanine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID36689305
SCHEMBL ID18317471
MeSH IDM0438671

Synonyms (17)

Synonym
mahanine
(r)-3,5-dimethyl-3-(4-methylpent-3-en-1-yl)-3,11-dihydropyrano[3,2-a]carbazol-9-ol
28360-49-8
AKOS026670251
SCHEMBL18317471
EX-A7585
(3r)-3,5-dimethyl-3-(4-methylpent-3-enyl)-11h-pyrano[3,2-a]carbazol-9-ol
HY-121368
(-)-mahanine
DTXSID701318055
CS-0081809
pyrano[3,2-a]carbazol-9-ol, 3,11-dihydro-3,5-dimethyl-3-(4-methyl-3-pentenyl)-, (r)-
(3r)-3,11-dihydro-3,5-dimethyl-3-(4-methyl-3-penten-1-yl)pyrano[3,2-a]carbazol-9-ol
KBJ2W7E9BH
pyrano[3,2-a]carbazol-9-ol, 3,11-dihydro-3,5-dimethyl-3-(4-methyl-3-penten-1-yl)-, (3r)-
mahanine, (-)-
(-)-mahanin

Research Excerpts

Overview

Mahanine is a novel carbazole alkaloid derived from the leaves of Murraya koenigii, commonly known as the curry leaf plant.

ExcerptReferenceRelevance
"Mahanine is a novel carbazole alkaloid derived from the leaves of Murraya koenigii, commonly known as the curry leaf plant, which grows widely across East-Asia."( A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells.
Amin, KS; Baishya, G; Banerjee, PP; Barua, NC; Bhattacharya, S; Jagadeesh, S; Rao, PG, 2014
)
1.12

Treatment

Mahanine treatment promoted a dose dependent increased in glucose uptake in L6 myotubes and adipocyte cells via activation of the Akt signaling pathway. Mahanine treatment results in a decline in phospho-Akt levels and a disruption in the interaction of Akt with DNMT1 and DNMT3B.

ExcerptReferenceRelevance
"Mahanine treatment promoted a dose dependent increased in glucose uptake in L6 myotubes and adipocyte cells via activation of the Akt signaling pathway."( Mahanine enhances the glucose-lowering mechanisms in skeletal muscle and adipocyte cells.
Athipornchai, A; Chiabchalard, A; Nooron, N; Suksamrarn, A, 2017
)
2.62
"Mahanine treatment results in a decline in phospho-Akt levels and a disruption in the interaction of Akt with DNMT1 and DNMT3B."( Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.
Agarwal, S; Amin, KS; Baishay, G; Banerjee, PP; Barua, NC; Bhattacharya, S; Jagadeesh, S; Rao, PG, 2013
)
2.55
"Mahanine treatment causes a time- and dose-dependent decline in AR protein levels, including truncated AR splice variants, in a panel of androgen-responsive and -independent prostate cancer cells."( A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells.
Amin, KS; Baishya, G; Banerjee, PP; Barua, NC; Bhattacharya, S; Jagadeesh, S; Rao, PG, 2014
)
1.12

Bioavailability

ExcerptReferenceRelevance
" The information on its bioavailability and the toxicity generated from the recent studies have also been incorporated in the review."( Phytochemical portfolio and anticancer activity of Murraya koenigii and its primary active component, mahanine.
Choudhury, P; Deb, PK; Devi, R; Dutta, KN; Gogoi, B; Kandimalla, R; Pal, BC; Samanta, SK; Talukdar, NC, 2018
)
0.7
" Formation of secondary plant metabolite(s) in medicinal plants depends on several factors and in this study the cause of variation in bioavailability and content of a vital bioactive phytochemical, mahanine in the MK leaves from different geographical locations of varying soil properties and weather parameters was determined."( Variation in biosynthesis of an effective anticancer secondary metabolite, mahanine in Murraya koenigii, conditional on soil physicochemistry and weather suitability.
Barge, SR; Das, M; Devi, A; Devi, R; Kandimalla, R; Karki, AK; Koiri, DJ; Kumar, A; Pal, BC; Samanta, SK; Sarma, PP; Talukdar, NC, 2020
)
0.98

Dosage Studied

ExcerptRelevanceReference
" The small molecule lead was not acutely toxic up to 550 mg/kg, and dosing at 10 mg/kg reduced human xenograft tumor volume by about 40%."( Fluorescent epigenetic small molecule induces expression of the tumor suppressor ras-association domain family 1A and inhibits human prostate xenograft.
Banerjee, PP; Brown, ML; Grindrod, SC; Jagadeesh, S; Paige, M; Sheikh, KD; Zhang, L, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (20.00)29.6817
2010's22 (73.33)24.3611
2020's2 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.03 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]